Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolus (EOLS) EBITDA Margin (2019 - 2026)

Evolus filings provide 8 years of EBITDA Margin readings, the most recent being 14.76% for Q1 2026.

  • On a quarterly basis, EBITDA Margin rose 1271.0% to 14.76% in Q1 2026 year-over-year; TTM through Mar 2026 was 14.2%, a 630.0% increase, with the full-year FY2025 number at 17.13%, up 199.0% from a year prior.
  • EBITDA Margin hit 14.76% in Q1 2026 for Evolus, down from 0.12% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 0.12% in Q4 2025 to a low of 63.32% in Q2 2022.
  • Median EBITDA Margin over the past 5 years was 27.47% (2025), compared with a mean of 29.4%.
  • Biggest five-year swings in EBITDA Margin: crashed -10421bps in 2022 and later soared 2646bps in 2023.
  • Evolus' EBITDA Margin stood at 30.09% in 2022, then soared by 37bps to 19.1% in 2023, then soared by 54bps to 8.88% in 2024, then surged by 101bps to 0.12% in 2025, then plummeted by -12109bps to 14.76% in 2026.
  • The last three reported values for EBITDA Margin were 14.76% (Q1 2026), 0.12% (Q4 2025), and 22.15% (Q3 2025) per Business Quant data.